Soluções e Reagentes da Farmacopeia Europeia (EP, Ph. Eur.)

As soluções e reagentes da Farmacopeia Europeia (Ph. Eur.) garantem que os produtos farmacêuticos atendam aos altos padrões de qualidade estabelecidos pela União Europeia. Essas soluções são essenciais para testar a pureza, potência e qualidade dos medicamentos. Na CymitQuimica, oferecemos uma ampla gama de soluções e reagentes em conformidade com a Ph. Eur., apoiando a pesquisa farmacêutica e os processos de controle de qualidade.

Ler mais

20
- 50
- 100
- 200

produtos por página. 9164 produtos desta categoria.

Dados do produto	Pureza	Gama de preços	Estimativa de entrega
Reagecon Simulated Gastric Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate REF: 07-DBC12-230	- - -	397,00 €	Qua 09 Out 24
Reagecon Ammonia Dilute R2 according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF: 07-1004703	- - -	57,00 €	Qua 09 Out 24
Reagecon Bromocresol Green, Methyl Red mixed Indicator according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF: 07-1012602	- - -	47,00 €	Qua 09 Out 24
Reagecon Diphenylamine Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF: 07-10321011	- - -	32,00 €	Qua 09 Out 24
Reagecon Diphenylamine R1 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF: 07-1032102	- - -	114,00 €	Qua 09 Out 24
Reagecon Cupri-Tartaric Solution 1 according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF: 07-1023300-ACAS: 7758-98-7	- - -	91,00 €	Qua 09 Out 24
Reagecon Concentrate to make Nitrate (NO3) 2ppm Standard Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.2) Limit Test REF: 07-5002102C	- - -	109,00 €	Qua 09 Out 24
Reagecon Phenolphthalein R1 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF: 07-1063703	- - -	114,00 €	Qua 09 Out 24
Reagecon Lead Acetate Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF: 07-1048103CAS: 6080-56-4	- - -	91,00 €	Qua 09 Out 24
Reagecon Acetate Buffer pH 4.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) REF: 07-DB06-121	- - -	237,00 €	Qua 09 Out 24
Reagecon Perchloric Acid Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF: 07-1062901	- - -	47,00 €	Qua 09 Out 24
Reagecon Simulated Gastric Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate REF: 07-DBC12-250	- - -	558,00 €	Qua 09 Out 24
Reagecon Nitric Acid Dilute according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF: 07-1058402CAS: 7697-37-2	- - -	47,00 €	Qua 09 Out 24
Reagecon GY3 Colour Reference Solution according to European Pharmacopoeia (EP) REF: 07-EPGY301	- - -	87,00 €	Qua 09 Out 24
Reagecon GY5 Colour Reference Solution according to European Pharmacopoeia (EP) REF: 07-EPGY501	- - -	87,00 €	Qua 09 Out 24
Reagecon Concentrate to make Potassium (K) 100ppm Standard Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.2) Limit Test REF: 07-5002400C	- - -	130,00 €	Qua 09 Out 24
Reagecon Iodine 0.05M according to European Pharmacopoeia (EP) Chapter 4 (4.2.2) REF: 07-3002700	- - -	70,00 €	Qua 09 Out 24
Reagecon Aluminium (Al) 200ppm Standard Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.2) Limit Test REF: 07-5000200	- - -	81,00 €	Qua 09 Out 24
Reagecon Anisaldehyde Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF: 07-1007301	- - -	47,00 €	Qua 09 Out 24
Reagecon Potassium Tetraiodomercurate Solution Alkaline Part B according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF: 07-1071600-B	- - -	56,00 €	Qua 09 Out 24

Soluções e Reagentes da Farmacopeia Europeia (EP, Ph. Eur.)

Reagecon Simulated Gastric Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate

Ref: 07-DBC12-230

Reagecon Ammonia Dilute R2 according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1004703

Reagecon Bromocresol Green, Methyl Red mixed Indicator according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1012602

Reagecon Diphenylamine Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-10321011

Reagecon Diphenylamine R1 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1032102

Reagecon Cupri-Tartaric Solution 1 according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1023300-A

Reagecon Concentrate to make Nitrate (NO3) 2ppm Standard Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.2) Limit Test

Ref: 07-5002102C

Reagecon Phenolphthalein R1 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1063703

Reagecon Lead Acetate Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1048103

Reagecon Acetate Buffer pH 4.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP)

Ref: 07-DB06-121

Reagecon Perchloric Acid Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1062901

Reagecon Simulated Gastric Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate

Ref: 07-DBC12-250

Reagecon Nitric Acid Dilute according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1058402

Reagecon GY3 Colour Reference Solution according to European Pharmacopoeia (EP)

Ref: 07-EPGY301

Reagecon GY5 Colour Reference Solution according to European Pharmacopoeia (EP)

Ref: 07-EPGY501

Reagecon Concentrate to make Potassium (K) 100ppm Standard Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.2) Limit Test

Ref: 07-5002400C

Reagecon Iodine 0.05M according to European Pharmacopoeia (EP) Chapter 4 (4.2.2)

Ref: 07-3002700

Reagecon Aluminium (Al) 200ppm Standard Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.2) Limit Test

Ref: 07-5000200

Reagecon Anisaldehyde Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1007301

Reagecon Potassium Tetraiodomercurate Solution Alkaline Part B according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1071600-B